We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.24%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$6.39B
AUM Growth
+$706M
(+12%)
Cap. Flow
+$807M
Cap. Flow
% of AUM
12.63%
Top 10 Holdings %
Top 10 Hldgs %
53.35%
Holding
886
New
91
Increased
283
Reduced
420
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$518M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$255M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$88.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$60.7M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$57.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$20.3M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$20M |
| 3 |
NVIDIA
NVDA
|
+$19.3M |
| 4 |
Texas Instruments
TXN
|
+$17.5M |
| 5 |
Qualcomm
QCOM
|
+$16.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 10.54% |
| 2 | Energy | 6.9% |
| 3 | Healthcare | 6.34% |
| 4 | Technology | 6.19% |
| 5 | Real Estate | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
126
DELISTED
Blueprint Medicines
BPMC
| $6.03M | 0.09% |
82,120
+27,608
| +51% | +$2.39M |
|
|
ONCE
127
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6M | 0.09% |
61,872
+11,269
| +22% | +$1.13M |
|
128
Exelixis
EXEL
$14.2B
| $5.96M | 0.09% |
336,921
+85,952
| +34% | +$1.74M |
|
|
MRTX
129
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.9M | 0.09% |
75,767
+23,314
| +44% | +$2.19M |
|
130
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.17B
| $5.89M | 0.09% |
293,988
+106,631
| +57% | +$2.08M |
|
131
Travelers Companies
TRV
$82.9B
| $5.88M | 0.09% |
39,568
-6,271
| -14% | -$932K |
|
132
APA Corp
APA
$12.3B
| $5.88M | 0.09% |
229,739
+28,068
| +14% | +$673K |
|
133
Ionis Pharmaceuticals
IONS
$9.14B
| $5.88M | 0.09% |
98,163
+18,299
| +23% | +$1.19M |
|
134
Aflac
AFL
$65.9B
| $5.84M | 0.09% |
111,545
-17,617
| -14% | -$930K |
|
|
GBT
135
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.82M | 0.09% |
119,973
+28,385
| +31% | +$1.48M |
|
|
NVTA
136
DELISTED
Invitae Corporation
NVTA
| $5.76M | 0.09% |
298,986
+41,880
| +16% | +$988K |
|
|
BNY
137
Bank of New York Mellon
BNY
$106B
| $5.73M | 0.09% |
126,833
-27,053
| -18% | -$1.2M |
|
|
SAGE
138
DELISTED
Sage Therapeutics
SAGE
| $5.69M | 0.09% |
40,561
+12,189
| +43% | +$2.04M |
|
139
Sarepta Therapeutics
SRPT
$1.63B
| $5.69M | 0.09% |
75,514
+34,167
| +83% | +$4.04M |
|
|
BLUE
140
DELISTED
bluebird bio
BLUE
| $5.68M | 0.09% |
4,774
+1,530
| +47% | +$2.34M |
|
141
MetLife
MET
$62.7B
| $5.65M | 0.09% |
119,789
-21,258
| -15% | -$1.01M |
|
|
MRO
142
DELISTED
Marathon Oil Corporation
MRO
| $5.64M | 0.09% |
459,920
+66,556
| +17% | +$861K |
|
143
Equity Residential
EQR
$25.5B
| $5.59M | 0.09% |
64,763
-8,849
| -12% | -$724K |
|
144
Prudential Financial
PRU
$43B
| $5.52M | 0.09% |
61,340
-10,167
| -14% | -$921K |
|
|
EXAS
145
DELISTED
Exact Sciences
EXAS
| $5.51M | 0.09% |
60,983
+15,723
| +35% | +$1.79M |
|
|
XEC
146
DELISTED
CIMAREX ENERGY CO
XEC
| $5.49M | 0.09% |
114,428
+14,437
| +14% | +$683K |
|
147
AvalonBay Communities
AVB
$27.2B
| $5.3M | 0.08% |
24,606
-3,592
| -13% | -$751K |
|
|
BHVN
148
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.25M | 0.08% |
125,778
+48,518
| +63% | +$2.05M |
|
|
FOLD
149
DELISTED
Amicus Therapeutics
FOLD
| $5.21M | 0.08% |
648,972
+213,367
| +49% | +$2.32M |
|
150
Moody's
MCO
$83.9B
| $5.09M | 0.08% |
24,850
-4,008
| -14% | -$840K |
|
Similar funds
CS
AF
SC
JG
SO
Rafferty Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Rafferty Asset Management held 886 positions worth $6.39B, up 12% from $5.69B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Rafferty Asset Management deployed $807M of net new capital in Q3 2019, opening 91 new positions and adding to 283 existing holdings. Its largest new stake was Invesco QQQ Trust: 469,050 shares worth $88.6M.
By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 14% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $20.3M trimmed.
- Rafferty Asset Management's largest Q3 2019 buy was Invesco QQQ Trust: 469,050 shares worth $88.6M.
- Rafferty Asset Management added most to VanEck Gold Miners ETF in Q3 2019, an estimated $518M increase.
- Rafferty Asset Management's biggest Q3 2019 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $20.3M.
- Rafferty Asset Management fully exited Anadarko Petroleum in Q3 2019, selling an estimated $8.5M.
- Rafferty Asset Management's ten largest holdings make up 53% of its $6.39B portfolio in Q3 2019.
- Rafferty Asset Management opened 91 new positions and closed 88 in Q3 2019.
- Rafferty Asset Management's portfolio value rose 12% quarter-over-quarter to $6.39B.
Based on Rafferty Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.